Sign in to fuzzto save your conversations, follow your research and come back anytime.
Senores Pharmaceuticals
SectorHealthcare
| Metric (₹ crore) | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 78.7 | 102.44 | 80.39 | 100.63 | 103.02 | 114.21 | 137.99 | 161.76 | 170.95 | 175.19 | 180.21 |
| Expenses | 63.55 | 80.05 | 59.07 | 77.36 | 77.33 | 94.77 | 103.83 | 112.25 | 120.55 | 127.7 | 126.45 |
| EBITDA | 15.15 | 22.39 | 21.32 | 23.27 | 25.69 | 19.44 | 34.16 | 49.51 | 50.4 | 47.49 | 53.76 |
| Depreciation | 3.25 | 3.71 | 3.52 | 3.89 | 4.2 | 5.23 | 5.99 | 8.09 | 7.86 | 9.3 | 9.94 |
| EBIT | 11.9 | 18.68 | 17.8 | 19.38 | 21.49 | 14.21 | 28.17 | 41.42 | 42.54 | 38.19 | 43.82 |
| Interest | 2.45 | 3.03 | 4.82 | 5.27 | 6.16 | 5.3 | 5.04 | 6.19 | 5.33 | 8.46 | 7.17 |
| Profit Before Tax | 9.45 | 15.65 | 12.98 | 14.11 | 15.33 | 8.91 | 23.13 | 35.23 | 37.21 | 29.73 | 36.65 |
| Net Profit | 7.11 | 14.18 | 10.91 | 13.07 | 16.43 | 17.97 | 21.18 | 30.12 | 33.58 | 36.67 | 30.45 |
| EPS | 4.01 | 8.03 | 3.39 | 3.92 | 5.04 | 3.81 | 4.6 | 6.54 | 7.29 | 7.96 | 6.61 |
| Metric (₹ crore) | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Operating Cash Flow | -10.45 | -1.08 | -25.7 | -45.92 |
| Investing Cash Flow | -24.44 | -48.29 | -53.73 | -429.48 |
| Financing Cash Flow | 36.46 | 46.25 | 86.98 | 573.13 |
| Net Cash Flow | 1.57 | -3.12 | 7.55 | 97.73 |
| Metric (₹ crore) | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Equity / Shareholders' Funds | 36.59 | 45.5 | 231.71 | 812.24 |
| Total Liabilities | 22.56 | 85.55 | 390.17 | 414.62 |
| Total Assets | 59.15 | 131.05 | 621.88 | 1,226.86 |